Salmonella typhi Vi polysaccharide capsular antigen — Drug Target
All drugs that target Salmonella typhi Vi polysaccharide capsular antigen — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- Typhoid Vi vaccine · International Vaccine Institute · polysaccharide vaccine · Immunology / Infectious Disease
The Typhoid Vi vaccine stimulates the immune system to produce antibodies and cellular immunity against Salmonella typhi by presenting the bacterial Vi polysaccharide capsular antigen.